Showing results (201-210 of 301) with videos related to

Sort By:
Pageof 31
Cancer Medicine|September 14, 2023
Real-world survival outcome comparing abiraterone acetate plus prednisone and enzalutamide for nonmetastatic castration-resistant prostate cancerTakuya Tsujino, Satoshi Tokushige, Kazumasa Komura, et al.
Journal of Neurosurgery|October 22, 2003
Transcriptional expression of survivin and its splice variants in brain tumors in humansYoshitaka Yamada, Toshihiko Kuroiwa, Toshimasa Nakagawa, et al.
World Journal of Urology|November 4, 2023
Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinomaTakuya Tsujino, Kazumasa Komura, Teruo Inamoto, et al.
The Prostate|March 15, 2026
The Prognostic Significance of Radiographic Progression Without PSA Progression in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line ARPI TherapyTakeshi Tsutsumi, Shogo Yamazaki, Takuya Matsuda, et al.
Anticancer Research|September 26, 2025
Real-world Outcomes of Enfortumab Vedotin in Elderly Patients With Metastatic Urothelial CarcinomaKyosuke Nishio, Kensuke Hirosuna, Taizo Uchimoto, et al.
Japanese Journal of Clinical Oncology|February 3, 2026
Age-stratified clinical outcomes and adverse events in patients with metastatic castration-sensitive prostate cancer receiving triplet therapy with darolutamide, androgen deprivation therapy, and docetaxelTaizo Uchimoto, Kensuke Hirosuna, Heima Niigawa, et al.
Clinical Genitourinary Cancer|October 25, 2023
Prognostic Impact of Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab: A Multicenter Retrospective StudyTakuhisa Nukaya, Kiyoshi Takahara, Atsuhiko Yoshizawa, et al.
Oncology|October 15, 2023
Predicting Objective Response of Pembrolizumab in Platinum-Refractory Urothelial Carcinoma Based on Neutrophil-Lymphocyte Ratio Fluctuation and Liver MetastasesKyosuke Nishio, Takuya Higashio, Kazumasa Komura, et al.
IJU Case Reports|April 23, 2026
Inferior Vena Cava Thrombosis After Nephrectomy of the Native Kidneys in Patients With Autosomal Dominant Polycystic Kidney DiseaseYuto Matsushita, Kyohei Watanabe, Taro Aoki, et al.
Molecular Cancer Therapeutics|October 1, 2014
The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancerNaokazu Ibuki, Mazyar Ghaffari, Hadas Reuveni, et al.
Pageof 31